Medical technology company Getinge (STO:GETI-B) announced on Tuesday the launch of Pulsiocare, an advanced hemodynamic monitoring platform that recently received CE certification.
The state-of-the-art device builds on Getinge's award-winning common user interface, offering a modern and intuitive platform for patient monitoring and hemodynamic assessment. Pulsiocare succeeds the PulsioFlex platform and features a mobile design with a rechargeable battery and responsive touchscreen.
The integration of Getinge's common user interface ensures a familiar and easy-to-navigate experience, reducing the learning curve for healthcare professionals.
Pulsiocare combines Getinge's proven PiCCO and ProAQT technologies into a single monitor. This innovation reflects Getinge's commitment to enhancing medical technology and improving patient care.
Johnson & Johnson agrees acquisition of V-Wave
Nightingale Health gains UKCA certification and expands with new laboratory
Talphera enrols first subject in NEPHRO CRRT study
China Pharma Holdings anticipates launch of Dry Eye Disease Therapeutic Device in early 2025
SOPHiA DDM Platform achieves IVDR certification, enhancing diagnostic precision
Medtronic reports FDA approval of Simplera CGM; partners with Abbott
OncoBeta expands Rhenium-SCT (Skin Cancer Therapy) treatment services in Italy
Labcorp's PGDx elio plasma focus Dx receives US FDA De Novo marketing authorisation
Verici Dx announces completion of Thermo Fisher Scientific licensing agreement
Polarean Imaging enters into trade-in agreement with University of Kansas Medical Center